Search research articles
Contact Us
Filters
Showing results (471-480 of 489) with videos related to
Page
of 49
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)
A Thiel, J Schetelig, W Pönisch, et al.
Journal of Global Antimicrobial Resistance
|
March 10, 2025
Plasmidome analyses of Klebsiella pneumoniae co-producing bla<sub>KPC-2</sub> and bla<sub>NDM-1</sub> in Southern Brazil: characterisation of mobile genetic elements
Mayana Kieling Hernandez Berdichevski, Rafaela R Guerra, Dariane C Pereira, et al.
Chemistry & Biology
|
March 13, 1999
Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
C Oefner, A Binggeli, V Breu, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
Andrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2000
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors
J Dumas, H Hatoum-Mokdad, R Sibley, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2000
Discovery of a new class of p38 kinase inhibitors
J Dumas, R Sibley, B Riedl, et al.
JAMA Surgery
|
August 18, 2016
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
Scott M Wilhelm, Tracy S Wang, Daniel T Ruan, et al.
European Journal of Preventive Cardiology
|
August 20, 2015
Sudden cardiac arrest in sports - need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation
E E Solberg, M Borjesson, S Sharma, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2001
p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas
A M Redman, J S Johnson, R Dally, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 489) with videos related to
Sort By:
Page
of 49
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)
A Thiel, J Schetelig, W Pönisch, et al.
Journal of Global Antimicrobial Resistance
|
March 10, 2025
Plasmidome analyses of Klebsiella pneumoniae co-producing bla<sub>KPC-2</sub> and bla<sub>NDM-1</sub> in Southern Brazil: characterisation of mobile genetic elements
Mayana Kieling Hernandez Berdichevski, Rafaela R Guerra, Dariane C Pereira, et al.
Chemistry & Biology
|
March 13, 1999
Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
C Oefner, A Binggeli, V Breu, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
Andrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2000
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors
J Dumas, H Hatoum-Mokdad, R Sibley, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2000
Discovery of a new class of p38 kinase inhibitors
J Dumas, R Sibley, B Riedl, et al.
JAMA Surgery
|
August 18, 2016
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
Scott M Wilhelm, Tracy S Wang, Daniel T Ruan, et al.
European Journal of Preventive Cardiology
|
August 20, 2015
Sudden cardiac arrest in sports - need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation
E E Solberg, M Borjesson, S Sharma, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2001
p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas
A M Redman, J S Johnson, R Dally, et al.
Page
of 49